Possible impact of HLA class I and class II on malignancies driven by a single germ‐line BRCA1 mutation
Article in International Journal of Immunogenetics (July 2023)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
HLA-DRB1: A new potential prognostic factor and therapeutic target of cutaneous melanoma and an indicator of tumor microenvironment remodeling
Article in PLOS ONE (September 2022)
Relevance of the MHC region for breast cancer susceptibility in Asians
Article in Breast Cancer (May 2022)